Is Teva Pharmaceuticals Stock a Buy?
Teva Pharmaceutical Industries (NYSE: TEVA) is a well known generic drugmaker that's attracted the attention of a number of well-known investors in the past. Most notably, Warren Buffett's Berkshire Hathaway bought shares of the company a number of years ago due, in no small part due to how cheap the stock was at the time.
While the drugmaker does have a couple of promising drugs on the horizon, there are also some major problems that investors should know about. Whether that be the loss of its previous patents or its alarmingly high debt, investors might want to take a closer look at this cheap healthcare stock before making any investment decisions.
Image source: Getty Images.
Source Fool.com
